Insulin like growth factor I (IGF-I) represents the key marker for the evaluation of Growth hormone (GH) status. As a large number of determinants including age, gender, genetic factors, nutrition, and disease states influence IGF-I serum levels, accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-I levels for adequate monitoring of patients with an over- or under-active GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11102-007-0035-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!